Morocco medicine price database

CEMIVIL 400 MG

imatinib

Public price

2.010,00 MAD

Active substance

imatinib

Laboratory

PROMOPHARM (HIKMA)

What is this medicine?

Imatinib mesylate is a kinase inhibitor indicated for the treatment of various types of leukemia, myeloproliferative diseases, and specific stromal tumors.

Verified summary

imatinib, Comprimé pelliculé, 400 MG, Boite de 30

Common uses

Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML),Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL),Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements,Aggressive systemic mastocytosis (ASM),Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL),Unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP),Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST),Adjuvant treatment following resection of Kit (CD117) positive GIST

Class

kinase inhibitor

Laboratory

PROMOPHARM (HIKMA)

Hospital price

1.761,00 MAD

Strength

400 MG

Form

Comprimé pelliculé

Presentation

Boite de 30

ATC code

L01XE01

Type

Générique

Therapeutic class

Antinéoplasique, inhibiteur de multikinase

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 2.010,00 MAD

Available presentations and strengths

Medicines with the same active substance